Pulmonary and nasal delivery of serum amyloid P

Details for Australian Patent Application No. 2010232591 (hide)

Owner Promedior, Inc.

Inventors Willett, W. Scott; Caimi, Richard J.; Murray, Lynne Anne

Agent Shelston IP

Pub. Number AU-A-2010232591

PCT Pub. Number WO2010/115032

Priority 61/211,609 01.04.09 US

Filing date 1 April 2010

Wipo publication date 7 October 2010

International Classifications

A61K 9/12 (2006.01) Medicinal preparations characterised by special physical form - Aerosols

A61J 3/02 (2006.01) Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/115032 Priority application(s): WO2010/115032

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010232593-Protein biomarkers for soft tissue disease diagnosis and as therapeutic targets for oral care intervention

2010232590-Anti bone-loss and anti attachment-loss effects of an oral composition